7R-Ahx-HBV Large envelope protein (219-243)

General Information


DRACP ID  DRACP04059

Peptide Name   7R-Ahx-HBV Large envelope protein (219-243)

Sequence  RRRRRRRXPTSNHSPTSCPPTCPGYRWMCLRRF

Sequence Length  33

UniProt ID  P03138 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antiviral



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C167H270N66O40S4

Absent amino acids  ADEIKQV

Common amino acids  R

Mass  465153

Pl  12.5

Basic residues  11

Acidic residues  0

Hydrophobic residues  3

Net charge  11

Boman Index  -16119

Hydrophobicity  -153.94

Aliphatic Index  11.82

Half Life 
  /

Extinction Coefficient cystines  7115

Absorbance 280nm  222.34

Polar residues  12

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21144865

Title  Artificial recombinant cell-penetrating peptides interfere with envelopment of hepatitis B virus nucleocapsid and viral production

Doi Not available

Year  2011

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16536

DRACP is developed by Dr.Zheng's team.